CD30-targeting immunoconjugates and bystander effects

Nat Rev Clin Oncol. 2015 Apr;12(4). doi: 10.1038/nrclinonc.2014.159-c1. Epub 2015 Mar 3.

Authors

Shigeo Masuda¹, Shigeru Miyagawa¹, Nagako Sougawa¹, Yoshiki Sawa¹

Affiliation

¹ Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

PMID: 25734636
DOI: 10.1038/nrclinonc.2014.159-c1

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Humans
Immunization, Passive / methods*
Immunoconjugates / therapeutic use*
Immunotherapy / trends*
Neoplasms / therapy*

Substances

Immunoconjugates